Drugs Made In America Acquisition (DMII) Assets Average (2025)

Drugs Made In America Acquisition (DMII) reported Assets Average of $503.0 million for Q4 2025, up 100.73% quarter-over-quarter from $250.6 million in Q3 2025.

Drugs Made In America Acquisition (DMII) Assets Average (2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has 1 years of Assets Average data on file, last reported at $503.0 million in Q4 2025.

  • Assets Average for Q4 2025 came in at $503.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $503.0 million (changed N/A YoY), and the FY2025 annual result was $252.5 million, changed N/A from the prior year.
  • Assets Average advanced to $503.0 million in Q4 2025 per DMII's latest filing, from $250.6 million in the prior quarter.
  • Over five years, Assets Average peaked at $503.0 million in Q4 2025 and troughed at $250.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - 472.34 Mn
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - 307.93 Mn
3 Berto Acquisition 311.56 Mn 311.56 Mn - 310.58 Mn
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 309.16 Mn
5 Centurion Acquisition 310.21 Mn 310.21 Mn - 309.64 Mn
6 WEN Acquisition 309.15 Mn 309.15 Mn - 307.14 Mn
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - 372.24 Mn
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - 271.71 Mn
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - 241.41 Mn
10 Drugs Made In America Acquisition 129.34 Mn 129.34 Mn - 502.98 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 502.98 Mn
Sep 30, 2025 250.57 Mn